Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus.
about
Metformin and body weightMetformin monotherapy for type 2 diabetes mellitusRisk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitusRisk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitusInsulin monotherapy versus combinations of insulin with oral hypoglycaemic agents in patients with type 2 diabetes mellitusMetformin monotherapy for type 2 diabetes mellitusTeneligliptin: a DPP-4 inhibitor for the treatment of type 2 diabetesUse of metformin in diseases of agingPhosphoinositides: Key modulators of energy metabolismCurrent therapeutic options in type 2 diabetes mellitus: a practical approachInsulin increases ceramide synthesis in skeletal muscleGlucose supply and insulin demand dynamics of antidiabetic agents.Comparison of Antidiabetic Regimens in Patients with Type 2 Diabetes Uncontrolled by Combination Therapy of Sulfonylurea and Metformin: Results of the MOHAS Disease Registry in Korea.Antiobesity pharmacotherapy in the management of type 2 diabetes.Further improvement in postprandial glucose control with addition of exenatide or sitagliptin to combination therapy with insulin glargine and metformin: a proof-of-concept study.Mathematical model for the contribution of individual organs to non-zero y-intercepts in single and multi-compartment linear models of whole-body energy expenditure.Weight considerations in pharmacotherapy for type 2 diabetesA comparison of intermediate and long-acting insulins in people with type 2 diabetes starting insulin: an observational database study.Saxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trialOrlistat in the treatment of Type 2 diabetes mellitus.A summary of the ADVANCE TrialDiet is critical for prolonged glycemic control after short-term insulin treatment in high-fat diet-induced type 2 diabetic male mice.Association of Allelic Variation in Genes Mediating Aspects of Energy Homeostasis with Weight Gain during Administration of Antipsychotic Drugs (CATIE Study).Recognition of fasting or overall hyperglycaemia when starting insulin treatment in patients with type 2 diabetes in general practice.Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus.A randomized, controlled study of once-daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetes.Effect of the addition of sitagliptin and miglitol on insulin-treated type 2 diabetes.Exenatide Treatment Causes Suppression of Serum Ghrelin Levels following Mixed Meal Test in Obese Diabetic Women.Does insulin detemir have a role in reducing risk of insulin-associated weight gain?Insulin analogs: impact on treatment success, satisfaction, quality of life, and adherence.Metformin.Insulin management in overweight or obese type 2 diabetes patients: the role of insulin glargine.The role of insulin detemir in overweight type 2 diabetes management.A study of dapagliflozin in patients with type 2 diabetes receiving high doses of insulin plus insulin sensitizers: applicability of a novel insulin-independent treatmentTreatment with sitagliptin or metformin does not increase body weight despite predicted reductions in urinary glucose excretion.Clinical experience with insulin detemir in patients with type 2 diabetes from the near East countries.Interplay between FGF21 and insulin action in the liver regulates metabolism.Clinical efficacy of a medically supervised outpatient high-protein, low-calorie diet program is equivalent in prediabetic, diabetic and normoglycemic obese patientsManaging highly insulin-resistant diabetes mellitus: weight loss approaches and medical management.Relationship of insulin dose, A1c lowering, and weight in type 2 diabetes: comparing insulin glargine and insulin detemir.
P2860
Q22250988-BDC72B4F-ABE4-48FC-B6DD-085EA08C1D5DQ24187392-3BAFC998-4EE5-4898-AF7F-CB9675E8D31BQ24235718-951FDA2B-21CD-477B-9376-40A46E7792C3Q24240522-AF28FEE0-687D-448D-9DEE-B4025E2BA2EDQ24246084-1C440683-2BDD-4BFA-8172-FAC447630E28Q24246552-59B6AAB1-25CB-49C9-856D-FF6DBED85604Q24628948-162BF60E-3CF8-45A1-A2E1-F5F87AD9BE3FQ26828760-36ED2F6E-C424-4924-9EF3-867EC3BF0468Q27022953-2880A197-0B74-4A79-BD22-9B1EEB3F21EEQ33723387-0EC52CDC-1AFC-4F54-8054-15955DC60517Q33736297-6A8FD3BD-0A71-4195-8AD2-DE44887E308EQ33828255-30BB9126-0FC1-464F-90C6-D147966092D0Q33849111-4F714E9D-B3D9-4D9E-B524-8FDA92B1E4F7Q33883725-CA1AD8B6-336D-42B7-B79D-39F5C6290FEBQ33932718-BFE0D3A7-EF7F-46A4-88BA-47B6220435BBQ33961322-0726FEF9-9FA2-4BA2-BCF3-890A7B867838Q34159414-A9CC6A78-D9D4-4009-A5C3-4A3C3F6DD1AEQ34565168-1DF28124-A4CC-4D1A-89B5-13180BA28D21Q34610019-D8A1D9F7-46B0-436C-9FBE-AF2C992414F8Q34628629-8CA5075A-373E-49DC-A500-8252CC9177C1Q35010412-5AC295C8-D7F0-401C-AF68-D91E21D083DFQ35027017-B35AB27F-D0B9-44CF-968E-70B7AA396C93Q35460642-F5798786-5EBE-4809-8B20-60CD37512D57Q36048033-3EA2178C-BF2D-4FFE-AED1-7C7CFB13F30DQ36283803-FAF7D1ED-B24E-4D34-9579-4C32B7FB8482Q36334537-30397F74-9A19-4E31-AAA0-6E52C25395D6Q36428062-E4812009-0BE7-4DB3-B12F-B5A125EEFA07Q36656331-6C83E5F6-3920-4683-96E4-A903A9B40305Q36772875-401AABAF-4F6C-4ED8-B92D-54BD6568B5ABQ36947990-659756EE-AF20-4048-9985-D8F8C72D1BC3Q37083602-431473B2-489D-4373-A324-67582F909BA0Q37199318-834D595B-8566-4D5B-9228-FD04E6C5895CQ37248234-A6AF85E0-B100-4620-AD74-C7A0FCC85D83Q37319128-F796CE20-CAA4-4C85-8104-87C2971944BEQ37404353-F3A8C133-ECE7-4CA9-BF72-ACB478577CAFQ37468419-5BBFDC18-722E-42D5-8340-7D52A6AAD7C5Q37524205-EC3DE1CB-B305-427C-BCDA-5268426A6328Q37614461-09848C0F-535A-44C5-8A3F-5E5683765DC6Q37682560-96665B2F-0A7D-4E18-B375-5BFFFE08824AQ37815511-073510AA-18E4-4A9C-AA83-9824ADB89DF3
P2860
Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Causes of weight gain during i ...... ith Type II diabetes mellitus.
@en
Causes of weight gain during i ...... ith Type II diabetes mellitus.
@nl
type
label
Causes of weight gain during i ...... ith Type II diabetes mellitus.
@en
Causes of weight gain during i ...... ith Type II diabetes mellitus.
@nl
prefLabel
Causes of weight gain during i ...... ith Type II diabetes mellitus.
@en
Causes of weight gain during i ...... ith Type II diabetes mellitus.
@nl
P921
P356
P1433
P1476
Causes of weight gain during i ...... ith Type II diabetes mellitus.
@en
P2093
Mäkimattila S
P2888
P304
P356
10.1007/S001250051172
P577
1999-04-01T00:00:00Z